These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 14534679

  • 1. Cisplatin and platinum drugs at the molecular level. (Review).
    Boulikas T, Vougiouka M.
    Oncol Rep; 2003; 10(6):1663-82. PubMed ID: 14534679
    [Abstract] [Full Text] [Related]

  • 2. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    Kelland LR, Sharp SY, O'Neill CF, Raynaud FI, Beale PJ, Judson IR.
    J Inorg Biochem; 1999 Oct; 77(1-2):111-5. PubMed ID: 10626362
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
    Reardon JT, Vaisman A, Chaney SG, Sancar A.
    Cancer Res; 1999 Aug 15; 59(16):3968-71. PubMed ID: 10463593
    [Abstract] [Full Text] [Related]

  • 7. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 15; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cisplatin: mode of cytotoxic action and molecular basis of resistance.
    Siddik ZH.
    Oncogene; 2003 Oct 20; 22(47):7265-79. PubMed ID: 14576837
    [Abstract] [Full Text] [Related]

  • 10. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
    Konstantakou EG, Voutsinas GE, Karkoulis PK, Aravantinos G, Margaritis LH, Stravopodis DJ.
    Int J Oncol; 2009 Aug 20; 35(2):401-16. PubMed ID: 19578756
    [Abstract] [Full Text] [Related]

  • 11. [Platinum salts: cytotoxic mechanisms of action, mechanisms of resistance of cancer cells, interactions with ionizing radiation, specificity of carboplatin].
    Rixe O.
    Bull Cancer; 2000 Aug 20; 87 Spec No():7-15. PubMed ID: 11082717
    [Abstract] [Full Text] [Related]

  • 12. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V, Nováková O.
    Drug Resist Updat; 2006 Jun 20; 9(3):111-22. PubMed ID: 16790363
    [Abstract] [Full Text] [Related]

  • 13. Different accumulation of cisplatin, oxaliplatin and JM216 in sensitive and cisplatin-resistant human cervical tumour cells.
    Martelli L, Di Mario F, Ragazzi E, Apostoli P, Leone R, Perego P, Fumagalli G.
    Biochem Pharmacol; 2006 Sep 14; 72(6):693-700. PubMed ID: 16844093
    [Abstract] [Full Text] [Related]

  • 14. Platinum resistance: laboratory findings and clinical implications.
    Muggia FM, Los G.
    Stem Cells; 1993 May 14; 11(3):182-93. PubMed ID: 8318904
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin.
    Hrstka R, Powell DJ, Kvardova V, Roubalova E, Bourougaa K, Candeias MM, Sova P, Zak F, Fåhraeus R, Vojtĕsek B.
    Anticancer Drugs; 2008 Apr 14; 19(4):369-79. PubMed ID: 18454047
    [Abstract] [Full Text] [Related]

  • 19. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK, Schadendorf D, Röckmann H.
    Melanoma Res; 2006 Dec 14; 16(6):527-35. PubMed ID: 17119454
    [Abstract] [Full Text] [Related]

  • 20. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H, Hisa T, Ogata A, Miyazaki A, Nonaka Y, Nishihira T, Osada I, Sairennji T, Sugiyama H, Furuya Y, Kidani Y, Takamoto S, Takahashi H, Eriguchi M.
    Biomed Pharmacother; 2009 Sep 14; 63(8):553-60. PubMed ID: 18571892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.